ArticleCancer control : journal of the Moffitt Cancer Center

Feasibility of Intravaginal Artesunate as an Adjuvant HPV & Cervical Precancer Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II Clinical Trial.

Annum Sadana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.